The global fight between Eli Lilly and Novo Nordisk for dominance in the red-hot weight-loss drug market is shifting to India, one of the fastest-growing pharmaceutical frontiers. As rising obesity and diabetes rates collide with expanding middle-class incomes, the country is becoming a pivotal battleground for the two drugmakers.On Thursday,…
Wall Street is within striking distance of new all-time highs, as a powerful combination of artificial intelligence optimism, geopolitical…
In the commercial centre of Cochabamba, the third largest city of Bolivia, cryptocurrencies are quickly becoming a necessity rather…
Brazil’s central bank expressed confidence in its capacity for keeping inflation close to the official target until the end…
Disagreements on import duties for auto components, steel, and farm goods have stalled trade talks between India and the…
The recent rise in retail sales growth in China due to stimulus measures is just temporary, according to Commerzbank…
The current outlook for gold and silver prices remain uncertain as the daily moving average convergence and divergence continues…
The United States and China have formally finalized a trade understanding first reached last month in Geneva, a move…
Shares of Nike surged as much as 10% in premarket trading on Friday after the company offered a more…